Recent

% | $
Quotes you view appear here for quick access.

Neuralstem, Inc. Message Board

investorgold 84 posts  |  Last Activity: May 27, 2015 9:12 AM Member since: Mar 10, 1999
  • investorgold by investorgold May 27, 2015 9:12 AM Flag

    Neuralstem (NYSE:CUR)‘s stock had its “buy” rating restated by equities researchers at Brean Capital in a research report issued on Tuesday. They currently have a $8.00 target price on the stock. Brean Capital’s price target points to a potential upside of 354.55% from the company’s current price.

    Shares of Neuralstem (NYSE:CUR) opened at 1.76 on Tuesday. Neuralstem has a one year low of $1.57 and a one year high of $4.81. The stock has a 50-day moving average of $1. and a 200-day moving average of $2.. The company’s market cap is $158.99 million.

    Neuralstem (NYSE:CUR) last posted its quarterly earnings results on Friday, May 8th. The company reported ($0.06) EPS for the quarter, meeting the Thomson Reuters consensus estimate of ($0.06). The company had revenue of $2.92 million for the quarter. Analysts expect that Neuralstem will post $-0.26 EPS for the current fiscal year.

    Separately, analysts at MLV & Co. initiated coverage on shares of Neuralstem in a research note on Tuesday, April 28th. They set a “buy” rating and a $6.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. Neuralstem presently has an average rating of “Buy” and an average price target of $7.00.

    Neuralstem, Inc is a development-stage company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stems cells and the use of small molecule drugs. The Company has developed and maintains a portfolio of patents and patent applications that form base for its research and development efforts in the area of neural stem cell research

    Sentiment: Strong Buy

  • Reply to

    Bought 5000 more today at 1.57

    by joeycav11 May 22, 2015 10:38 PM
    investorgold investorgold May 23, 2015 4:37 AM Flag

    me too !!!

    Sentiment: Strong Buy

  • investorgold by investorgold May 22, 2015 1:58 AM Flag

    New Positions
    6 72,897

    Sold Out Positions
    8 1,547,349

    Sentiment: Strong Buy

  • Reply to

    look SRPT and shorts !!!!!

    by investorgold May 20, 2015 5:33 AM
    investorgold investorgold May 20, 2015 10:22 AM Flag

    Just saw Cramer & David Faber on CNBC talking about SRPT. Cramer negative and uninformed about SRPT. Favors BMRN for all the wrong reasons. What a fool.

    Sentiment: Strong Buy

  • Reply to

    SRPT On CNBC With Cramer

    by djdm007 May 20, 2015 9:30 AM
    investorgold investorgold May 20, 2015 10:19 AM Flag

    he is short with his guys !!!!

    Sentiment: Strong Buy

  • investorgold investorgold May 20, 2015 10:06 AM Flag

    you are a stemcell fuzzy !!

    Sentiment: Strong Buy

  • Reply to

    1.63 is a 2 year low !!!!

    by investorgold May 20, 2015 5:21 AM
    investorgold investorgold May 20, 2015 7:56 AM Flag

    I have you on ignored !!! sorry

    Sentiment: Strong Buy

  • investorgold by investorgold May 20, 2015 5:33 AM Flag

    will tell you cur very soon !!!!

    Sentiment: Strong Buy

  • investorgold by investorgold May 20, 2015 5:21 AM Flag

    we will get higher very soon !!!

    Sentiment: Strong Buy

  • investorgold investorgold May 12, 2015 11:27 AM Flag

    reporting day Friday 15th !!!! so low stockprice good for buyers !!!

    Sentiment: Strong Buy

  • investorgold investorgold May 12, 2015 2:58 AM Flag

    Neuralstem (NYSE:CUR) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 13,536,365 shares, an increase of 0.3% from the April 15th total of 13,500,797 shares, American Banking News reports. Approximately 15.6% of the shares of the stock are short sold. Based on an average daily volume of 561,187 shares, the days-to-cover ratio is currently 24.1 days.

    A number of research firms have recently commented on CUR. Analysts at MLV & Co. initiated coverage on shares of Neuralstem in a research note on Tuesday, April 28th. They set a “buy” rating and a $6.00 price target on the stock. Separately, analysts at Brean Capital initiated coverage on shares of Neuralstem in a research note on Thursday, March 12th. They set a “positive” rating on the stock. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $7.00.

    Shares of Neuralstem (NYSE:CUR) opened at 1.83 on Tuesday. Neuralstem has a 52 week low of $1.57 and a 52 week high of $4.81. The stock’s 50-day moving average is $1. and its 200-day moving average is $2.. The company’s market cap is $164.16 million.

    Sentiment: Strong Buy

  • Reply to

    accumulating again

    by hundoghouse May 6, 2015 4:00 PM
    investorgold investorgold May 7, 2015 5:35 AM Flag

    I called stahlz2000 but no answer over the last 1/2 year ?????

    Sentiment: Strong Buy

  • Reply to

    I´m holding 350k CUR at average 2.90 !!

    by investorgold May 1, 2015 10:04 AM
    investorgold investorgold May 1, 2015 12:52 PM Flag

    can you see I´m a member since 1999 Holding CUR more #$%$ year !!!!

    Sentiment: Strong Buy

  • Reply to

    I´m holding 350k CUR at average 2.90 !!

    by investorgold May 1, 2015 10:04 AM
    investorgold investorgold May 1, 2015 12:39 PM Flag

    but you got the message Boy !!!

    Sentiment: Strong Buy

  • I´v the stock will fail belove 1.00 I will buy another 100k !! I´m a big beliver in this Company !!!!!

    Sentiment: Strong Buy

  • Maxim Group LLC acted as sole book-running manager and Chardan Capital Markets, LLC acted as co-manager for the offering. Meyers Associates, L.P. and IFS Securities, Inc. acted as financial advisors for the offering.

    Sentiment: Strong Buy

  • investorgold by investorgold Apr 28, 2015 11:27 AM Flag

    Show: All Ratings For This Stock Only the Most Recent Rating From Each Brokerage

    Date

    Firm

    Action

    Rating

    Price Target

    Details

    Share

    4/28/2015 MLV & Co. Initiated Coverage Buy $6.00 View Tweet This Rating Share This Rating on StockTwits
    3/12/2015 Brean Capital Initiated Coverage Positive View Tweet This Rating Share This Rating on StockTwits
    3/6/2015 Brean Capital Set Price Target Buy $8.00 View Tweet This Rating Share This Rating on StockTwits
    2/18/2015 Brean Capital Initiated Coverage Buy $8.00 View Tweet This Rating Share This Rating on StockTwits
    10/9/2014 ING Group Reiterated Rating Buy View Tweet This Rating Share This Rating on StockTwits
    9/8/2014 HC Wainright Initiated Coverage Neutral View Tweet This Rating Share This Rating on StockTwits
    8/8/2014 Aegis Reiterated Rating Buy View Tweet This Rating Share This Rating on StockTwits
    6/25/2014 Aegis Boost Price Target Buy $6.00 - $7.00 View Tweet This Rating Share This Rating on StockTwits
    5/27/2014 Aegis Boost Price Target $6.00 View Tweet This Rating Share This Rating on StockTwits
    8/16/2013 Aegis Reiterated Rating Buy View

    Sentiment: Strong Buy

  • Reply to

    Short iinterest not published for CUR

    by edgarferrari Apr 11, 2015 11:43 PM
    investorgold investorgold Apr 12, 2015 4:10 AM Flag

    Bought $CUR again. Most interested in NSI-189 & NSI-532.IGF. Been digging into some nootropic websites & it seems that NSI-189 has become extremely popular even before being legally available to the public. Many users are going to extreme lengths to get their hands on it. There are quite a few large (public & private) groups discussing benefits of use & ways to procure sources of substantial quantities of NSI-189. Several users have resorted to buying from questionable underground sellers b/c Neuralstem has been sending out cease and desist letters to the more trusted vendors. I'm not condoning the illegal sale or purchase of NSI-189. I just thought it was worth pointing out that if people are going through this much trouble to buy it, Neuralstem must be onto something

    Sentiment: Strong Buy

  • Reply to

    Short iinterest not published for CUR

    by edgarferrari Apr 11, 2015 11:43 PM
    investorgold investorgold Apr 12, 2015 4:07 AM Flag

    Neuralstem (NYSE:CUR) saw a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 13,698,574 shares, a growth of 2.9% from the March 13th total of 13,311,581 shares, StockRatingsNetwork reports. Approximately 16.4% of the company’s stock are sold short. Based on an average trading volume of 1,578,899 shares, the short-interest ratio is presently 8.7 days.

    Sentiment: Strong Buy

  • investorgold by investorgold Apr 8, 2015 12:15 PM Flag

    What´s happen with CUR !!!

    Sentiment: Strong Buy

CUR
1.51-0.03(-1.95%)Jun 1 4:00 PMEDT